Abstract:Cardiovascular disease and malignancy are the most common cause of death in Non-alcoholic Steatohepatitis (NASH) patients. Aside from lifestyle modification, there is currently no treatment for NASH. Activation of Liver Receptor Homolog-1 (Lrh-1), known to bind phospholipid ligands, has been shown to effectively reduce liver triglyceride (TG) in DIO mice, raising Lrh-1 as a possible target for treating NASH. Despite this finding, hepatic TGs are equivalent in controls and liver-specific Lrh-1 knockout (LKO or
… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.